These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2843388)

  • 41. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 42. The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate.
    Ball EF; Shaw PJ; Ince PG; Johnson M
    Brain Res; 1994 Sep; 658(1-2):209-18. PubMed ID: 7834343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a projection from the lateral preoptic area and substantia innominata to the 'mesencephalic locomotor region' in the rat.
    Swanson LW; Mogenson GJ; Gerfen CR; Robinson P
    Brain Res; 1984 Mar; 295(1):161-78. PubMed ID: 6201228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the autoradiographic binding distribution of [3H]-gabapentin with excitatory amino acid receptor and amino acid uptake site distributions in rat brain.
    Thurlow RJ; Hill DR; Woodruff GN
    Br J Pharmacol; 1996 Jun; 118(3):457-65. PubMed ID: 8762065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-related functional changes of the glutamate receptor channels in rat Meynert neurones.
    Akaike N; Rhee JS
    J Physiol; 1997 Nov; 504 ( Pt 3)(Pt 3):665-81. PubMed ID: 9401973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular messengers associated with excitatory amino acid (EAA) receptors.
    Bockaert J; Dumuis A; Manzoni O; Nargeot J; Oomagari K; Pin JP; Rassendren F; Sebben M; Sladeczek F
    Adv Exp Med Biol; 1990; 268():79-91. PubMed ID: 1981654
    [No Abstract]   [Full Text] [Related]  

  • 48. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct.
    Kato T; Hirano A; Katagiri T; Sasaki H; Yamada S
    Ann Neurol; 1988 Jun; 23(6):620-3. PubMed ID: 3408244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):201-3. PubMed ID: 6707659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Amino acid and peptide as excitatory neurotransmitters].
    Onodera K; Takeuchi A
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(4 Suppl):734-42. PubMed ID: 1692145
    [No Abstract]   [Full Text] [Related]  

  • 51. Early cytoarchitectonic development of the anlage of the basal nucleus of Meynert in the human fetus.
    Kracun I; Rösner H
    Int J Dev Neurosci; 1986; 4(2):143-9. PubMed ID: 3455579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
    Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uptake, localization and release of taurine in the rat basal ganglia.
    Della Corte L; Clarke DJ; Bolam JP; Smith AD
    Adv Exp Med Biol; 1987; 217():285-94. PubMed ID: 3434424
    [No Abstract]   [Full Text] [Related]  

  • 54. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
    Nakano I; Hirano A
    Ann Neurol; 1984 May; 15(5):415-8. PubMed ID: 6732189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
    Samadi P; Grégoire L; Morissette M; Calon F; Hadj Tahar A; Bélanger N; Dridi M; Bédard PJ; Di Paolo T
    Neuropharmacology; 2008 Feb; 54(2):258-68. PubMed ID: 18001807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy.
    McDonald JW; Garofalo EA; Hood T; Sackellares JC; Gilman S; McKeever PE; Troncoso JC; Johnston MV
    Ann Neurol; 1991 May; 29(5):529-41. PubMed ID: 1650160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurons in the basal forebrain complex of the rat: a Golgi study.
    Brauer K; Schober W; Werner L; Winkelmann E; Lungwitz W; Hajdu F
    J Hirnforsch; 1988; 29(1):43-71. PubMed ID: 3385197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Les agents provocateurs: a series on the pharmacology of excitatory amino acids.
    Lodge D; Collingridge G
    Trends Pharmacol Sci; 1990 Jan; 11(1):22-4. PubMed ID: 2155494
    [No Abstract]   [Full Text] [Related]  

  • 59. Excitatory amino acid uptake sites in the human nucleus of Meynert.
    Charlton FA; Candy JM
    Eur J Pharmacol; 1988 Jun; 151(1):163-4. PubMed ID: 2843388
    [No Abstract]   [Full Text] [Related]  

  • 60. Autoradiographic demonstration of 5HT1 binding sites in the primate basal nucleus of Meynert.
    Mitchell IJ; Stuart AM; Slater P; Unwin HP; Crossman AR
    Eur J Pharmacol; 1984 Sep; 104(1-2):189-90. PubMed ID: 6499916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.